Bruker Cellular Analysis, Inc. Annual Return On Equity in % from 2019 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Bruker Cellular Analysis, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2022.
  • Bruker Cellular Analysis, Inc. Return On Equity for the quarter ending June 30, 2023 was -87.5 %, a 104% decline year-over-year.
  • Bruker Cellular Analysis, Inc. annual Return On Equity for 2022 was -58.7 %, a 84.7% decline from 2021.
  • Bruker Cellular Analysis, Inc. annual Return On Equity for 2021 was -31.8 %, a 21.9% decline from 2020.
  • Bruker Cellular Analysis, Inc. annual Return On Equity for 2020 was -26.1 %, a 25.9% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -58.7 -26.9 -84.7% Jan 1, 2022 Dec 31, 2022
2021 -31.8 -5.72 -21.9% Jan 1, 2021 Dec 31, 2021
2020 -26.1 -5.36 -25.9% Jan 1, 2020 Dec 31, 2020
2019 -20.7 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.